128 related articles for article (PubMed ID: 16876864)
1. Complement receptor 2, natural antibodies and innate immunity: Inter-relationships in B cell selection and activation.
Holers VM; Kulik L
Mol Immunol; 2007 Jan; 44(1-3):64-72. PubMed ID: 16876864
[TBL] [Abstract][Full Text] [Related]
2. Biophysical investigations of complement receptor 2 (CD21 and CR2)-ligand interactions reveal amino acid contacts unique to each receptor-ligand pair.
Kovacs JM; Hannan JP; Eisenmesser EZ; Holers VM
J Biol Chem; 2010 Aug; 285(35):27251-27258. PubMed ID: 20558730
[TBL] [Abstract][Full Text] [Related]
3. Lupus-associated innate receptors drive extrafollicular evolution of autoreactive B cells.
Zhu DY; Maurer DP; Castrillon C; Deng Y; Mohamed FAN; Ma M; Schmidt AG; Lingwood D; Carroll MC
bioRxiv; 2024 Jan; ():. PubMed ID: 38260501
[TBL] [Abstract][Full Text] [Related]
4. Identification of a novel mutation in complement receptor 2 in Chinese familial systemic lupus erythematosus.
Tang Y; Luo Y
Arch Rheumatol; 2022 Dec; 37(4):566-573. PubMed ID: 36879571
[TBL] [Abstract][Full Text] [Related]
5. Role of Complement System in Kidney Transplantation: Stepping From Animal Models to Clinical Application.
Qi R; Qin W
Front Immunol; 2022; 13():811696. PubMed ID: 35281019
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the Complement System by Neoplastic Disease of the Central Nervous System.
Yarmoska SK; Alawieh AM; Tomlinson S; Hoang KB
Front Immunol; 2021; 12():689435. PubMed ID: 34671342
[TBL] [Abstract][Full Text] [Related]
7. Halting targeted and collateral damage to red blood cells by the complement system.
Jalink M; de Boer ECW; Evers D; Havinga MQ; Vos JMI; Zeerleder S; de Haas M; Jongerius I
Semin Immunopathol; 2021 Dec; 43(6):799-816. PubMed ID: 34191092
[TBL] [Abstract][Full Text] [Related]
8. Natural immunoglobulin M-based delivery of a complement alternative pathway inhibitor in mouse models of retinal degeneration.
Annamalai B; Parsons N; Nicholson C; Joseph K; Coughlin B; Yang X; Jones BW; Tomlinson S; Rohrer B
Exp Eye Res; 2021 Jun; 207():108583. PubMed ID: 33878326
[TBL] [Abstract][Full Text] [Related]
9. Significance of Complement System in Ischemic Stroke: A Comprehensive Review.
Ma Y; Liu Y; Zhang Z; Yang GY
Aging Dis; 2019 Apr; 10(2):429-462. PubMed ID: 31011487
[TBL] [Abstract][Full Text] [Related]
10. The role of the complement system in traumatic brain injury: a review.
Hammad A; Westacott L; Zaben M
J Neuroinflammation; 2018 Jan; 15(1):24. PubMed ID: 29357880
[TBL] [Abstract][Full Text] [Related]
11. Targeting pathogenic postischemic self-recognition by natural IgM to protect against posttransplantation cardiac reperfusion injury.
Atkinson C; Qiao F; Yang X; Zhu P; Reaves N; Kulik L; Goddard M; Holers VM; Tomlinson S
Circulation; 2015 Mar; 131(13):1171-80. PubMed ID: 25825397
[TBL] [Abstract][Full Text] [Related]
12. Deficiency of complement receptors CR2/CR1 in Cr2⁻/⁻ mice reduces the extent of secondary brain damage after closed head injury.
Neher MD; Rich MC; Keene CN; Weckbach S; Bolden AL; Losacco JT; Patane J; Flierl MA; Kulik L; Holers VM; Stahel PF
J Neuroinflammation; 2014 May; 11():95. PubMed ID: 24885042
[TBL] [Abstract][Full Text] [Related]
13. TLR9 is dispensable for intestinal ischemia/reperfusion-induced tissue damage.
Slone EA; Pope MR; Roth M; Welti R; Fleming SD
Am J Clin Exp Immunol; 2012; 1(2):124-135. PubMed ID: 23205322
[TBL] [Abstract][Full Text] [Related]
14. Complement activation in the injured central nervous system: another dual-edged sword?
Brennan FH; Anderson AJ; Taylor SM; Woodruff TM; Ruitenberg MJ
J Neuroinflammation; 2012 Jun; 9():137. PubMed ID: 22721265
[TBL] [Abstract][Full Text] [Related]
15. Challenging the role of adaptive immunity in neurotrauma: Rag1(-/-) mice lacking mature B and T cells do not show neuroprotection after closed head injury.
Weckbach S; Neher M; Losacco JT; Bolden AL; Kulik L; Flierl MA; Bell SE; Holers VM; Stahel PF
J Neurotrauma; 2012 Apr; 29(6):1233-42. PubMed ID: 22335783
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of inflammation and tissue injury after major trauma--is complement the "bad guy"?
Neher MD; Weckbach S; Flierl MA; Huber-Lang MS; Stahel PF
J Biomed Sci; 2011 Nov; 18(1):90. PubMed ID: 22129197
[TBL] [Abstract][Full Text] [Related]
17. Marginal zone B cells are naturally reactive to collagen type II and are involved in the initiation of the immune response in collagen-induced arthritis.
Carnrot C; Prokopec KE; Råsbo K; Karlsson MC; Kleinau S
Cell Mol Immunol; 2011 Jul; 8(4):296-304. PubMed ID: 21358667
[TBL] [Abstract][Full Text] [Related]
18. CR2+ marginal zone B cell production of pathogenic natural antibodies is C3 independent.
Woods KM; Pope MR; Hoffman SM; Fleming SD
J Immunol; 2011 Feb; 186(3):1755-62. PubMed ID: 21187447
[TBL] [Abstract][Full Text] [Related]
19. Domain V peptides inhibit beta2-glycoprotein I-mediated mesenteric ischemia/reperfusion-induced tissue damage and inflammation.
Fleming SD; Pope MR; Hoffman SM; Moses T; Bukovnik U; Tomich JM; Wagner LM; Woods KM
J Immunol; 2010 Nov; 185(10):6168-78. PubMed ID: 20956350
[TBL] [Abstract][Full Text] [Related]
20. The complement system.
Sarma JV; Ward PA
Cell Tissue Res; 2011 Jan; 343(1):227-35. PubMed ID: 20838815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
